This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Abcellera Biologies Inc., Abcellera Biologics Inc.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3,696 
2 out of 2 
1 out of 2 Years Active: 2022-2024
Title: Olubukola Abiona: Innovator in Anti-Coronavirus Antibodies
Introduction
Olubukola Abiona is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-coronavirus antibodies. With a total of 3 patents, his work is pivotal in addressing the challenges posed by SARS-CoV and SARS-CoV-2.
Latest Patents
Abiona's latest patents focus on antibodies that bind to the spike proteins of SARS-CoV and SARS-CoV-2. These innovations include methods for treating or preventing conditions associated with SARS or COVID-19, as well as techniques for detecting these viruses. His work is crucial in the ongoing fight against the coronavirus pandemic.
Career Highlights
Throughout his career, Abiona has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Abcellera Biologics Inc. His experience in these institutions has allowed him to contribute significantly to research and development in the field of infectious diseases.
Collaborations
Abiona has collaborated with talented individuals, including Kathryn Westendorf and Stefanie Zentelis, who have supported his research endeavors. Their combined expertise has enhanced the impact of his work in the scientific community.
Conclusion
Olubukola Abiona's innovative contributions to the development of anti-coronavirus antibodies highlight his importance in the field of biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile